Understanding immune checkpoint inhibitors-related myocarditis: Mechanisms and targeted therapeutic pathways
Theranostics · 17.06.2026 · 16 (13) · 7715-7734
DOI: 10.7150/thno.127500 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, erschienen am 17.06.2026. Verfasst von Wenxiao Xia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, China. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Myocarditis. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, China.
Zitieren
APA
Xia, W., Zhang, H., Liu, L., Tu, C., & Song, X. (2026). Understanding immune checkpoint inhibitors-related myocarditis: Mechanisms and targeted therapeutic pathways. Theranostics, 16(13), 7715-7734. https://doi.org/10.7150/thno.127500
Vancouver
Xia W, Zhang H, Liu L, Tu C, Song X. Understanding immune checkpoint inhibitors-related myocarditis: Mechanisms and targeted therapeutic pathways. Theranostics. 2026;16(13):7715-7734. doi:10.7150/thno.127500
BibTeX
@article{Xia2026,
author = {Xia, Wenxiao and Zhang, Huan and Liu, Libo and Tu, Chenchen and Song, Xiantao},
title = {Understanding immune checkpoint inhibitors-related myocarditis: Mechanisms and targeted therapeutic pathways},
journal = {Theranostics},
year = {2026},
volume = {16},
number = {13},
pages = {7715--7734},
doi = {10.7150/thno.127500}
}
EUVIMED